Recombinant Human Antibody (C38-VRC16. 01) scFv Fragment is specific to HIV-1 gp160. This scFv fragment neutralized 58% of HIV-1 strains.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
PABL-177 | Human Anti-HIV-1 gp160 Recombinant Antibody (PABL-177) | WB, ELISA, Neut, FuncS | Human IgG |
PABL-178 | Human Anti-HIV-1 gp160 Recombinant Antibody (clone 3H+109L) | WB, ELISA, FuncS | Human IgG |
PABL-179 | Human Anti-HIV-1 gp160 Recombinant Antibody (clone PGT128) | WB, ELISA, FuncS | Human IgG |
PABL-180 | Human Anti-HIV-1 gp160 Recombinant Antibody (clone VRC08C) | WB, ELISA, Neut, FuncS | Human IgG, κ |
PABL-181 | Human Anti-HIV-1 gp160 Recombinant Antibody (clone VRC13.01) | FC, Neut, FuncS | Human IgG |
CAT | Product Name | Application | Type |
---|---|---|---|
PSBL-177 | Human Anti-HIV-1 gp160 Recombinant Antibody; scFv Fragment (PSBL-177) | WB, ELISA, Neut, FuncS | Human scFv |
PSBL-178 | Human Anti-HIV-1 gp160 Recombinant Antibody (clone 3H+109L); scFv Fragment | WB, ELISA, FuncS | Human scFv |
PSBL-179 | Human Anti-HIV-1 gp160 Recombinant Antibody (clone PGT128); scFv Fragment | WB, ELISA, FuncS | Human scFv |
PSBL-382 | Human Anti-HIV-1 gp160 Recombinant Antibody (clone VRC08); scFv Fragment | Neut, FuncS | Human scFv |
PFBW-163 | Human Anti-HIV-1 gp160 Recombinant Antibody (clone 268-D); Fab Fragment | ELISA, Neut | Human Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
MRO-086LC | Anti-HIV-1 gp160 Recombinant Antibody (1C1) | ELISA | Mouse antibody |
MRO-087LC | Anti-HIV-1 gp160 Recombinant Antibody (1H9) | ELISA | Mouse antibody |
MRO-086LC-F(E) | Anti-HIV-1 gp160 Recombinant Antibody Fab Fragment (1C1) | ELISA | Mouse antibody |
MRO-087LC-F(E) | Anti-HIV-1 gp160 Recombinant Antibody Fab Fragment (1H9) | ELISA | Mouse antibody |
MRO-088LC-F(E) | Anti-HIV-1 gp160 Recombinant Antibody Fab Fragment (2D7) | ELISA | Mouse antibody |
CAT | Product Name | Application | Type |
---|---|---|---|
MRO-075LC-F(E) | Anti-HIV-1 gp160 Recombinant Antibody Fab Fragment (24G3) | ELISA | Human antibody |
MRO-080LC-F(E) | Anti-HIV-1 gp160 Recombinant Antibody Fab Fragment (81C7) | ELISA | Human antibody |
MRO-091LC-F(E) | Anti-HIV-1 gp160 Recombinant Antibody Fab Fragment (MAb CL1) | ELISA | Human antibody |
MRO-100LC-F(E) | Anti-HIV-1 gp160 Recombinant Antibody Fab Fragment (N7019b) | ELISA | Human antibody |
MRO-101LC-F(E) | Anti-HIV-1 gp160 Recombinant Antibody Fab Fragment (K24-3b) | ELISA | Human antibody |
CAT | Product Name | Application | Type |
---|---|---|---|
MRO-3754CQ-F(E) | Human Anti-HIV-1 gp160 Recombinant Antibody (clone RV110026); Fab Fragment | ELISA, WB | Human Fab |
MRO-3755CQ-F(E) | Human Anti-HIV-1 gp160 Recombinant Antibody (clone 989-D); Fab Fragment | FC | Human Fab |
MRO-3756CQ-F(E) | Human Anti-HIV-1 gp160 Recombinant Antibody (clone m66S28LCH); Fab Fragment | Neut | Human Fab |
MRO-3757CQ-F(E) | Human Anti-HIV-1 gp160 Recombinant Antibody (clone m66G30LCK); Fab Fragment | Neut | Human Fab |
MRO-3758CQ-F(E) | Human Anti-HIV-1 gp160 Recombinant Antibody (clone m66S31LCK); Fab Fragment | Neut | Human Fab |
There are currently no Customer reviews or questions for PSBL-551. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.